Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Kabir

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
The Lancet. Psychiatry|July 11, 2021
Comparison of a theoretically driven cognitive therapy (the Feeling Safe Programme) with befriending for the treatment of persistent persecutory delusions: a parallel, single-blind, randomised controlled trialDaniel Freeman, Richard Emsley, Rowan Diamond, et al.
Schizophrenia Bulletin|April 29, 2024
Measurement of Adverse Events in Studies of Digital Health Interventions for Psychosis: Guidance and Recommendations Based on a Literature Search and Framework Analysis of Standard Operating ProceduresEmily Eisner, Cara Richardson, Neil Thomas, et al.
Behavioural and Cognitive Psychotherapy|November 9, 2023
Automated VR therapy for improving positive self-beliefs and psychological well-being in young patients with psychosis: a proof of concept evaluation of Phoenix VR self-confidence therapyDaniel Freeman, Jason Freeman, Memoona Ahmed, et al.
Psychological Medicine|June 14, 2022
Cognitive bias modification for paranoia (CBM-pa): a randomised controlled feasibility study in patients with distressing paranoid beliefsJenny Yiend, Charlene L M Lam, Nora Schmidt, et al.
BMJ Open|December 27, 2023
Randomised controlled trial of automated VR therapy to improve positive self-beliefs and psychological well-being in young people diagnosed with psychosis: a study protocol for the Phoenix VR self-confidence therapy trialDaniel Freeman, Jason Freeman, Aitor Rovira, et al.
BMJ Mental Health|November 12, 2025
Computerised adaptive testing across the paranoia continuumDaniel Freeman, Sinéad Lambe, Felicity Waite, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|September 4, 2024
Aripiprazole/Sertraline Combination: Clinical and Cost-Effectiveness in Comparison With Quetiapine for the Treatment of Bipolar Depression (ASCEnD Trial)-Protocol for a Nested Qualitative StudyIsobel Hoppe, Stuart Watson, Caroline Kemp, et al.
The Lancet. Psychiatry|September 2, 2018
Identifying research priorities for digital technology in mental health care: results of the James Lind Alliance Priority Setting PartnershipChris Hollis, Stephanie Sampson, Lucy Simons, et al.
Journal of Medical Internet Research|November 18, 2022
Estimating the Economic Value of Automated Virtual Reality Cognitive Therapy for Treating Agoraphobic Avoidance in Patients With Psychosis: Findings From the gameChange Randomized Controlled Clinical TrialJames Altunkaya, Michael Craven, Sinéad Lambe, et al.
Trials|December 2, 2024
Assessing the efficacy and safety of STOP (successful treatment for paranoia)-an app-based cognitive bias modification therapy for paranoia: a randomised clinical trial protocolJenny Yiend, Rayan Taher, Carolina Fialho, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
The Lancet. Psychiatry|July 11, 2021
Comparison of a theoretically driven cognitive therapy (the Feeling Safe Programme) with befriending for the treatment of persistent persecutory delusions: a parallel, single-blind, randomised controlled trialDaniel Freeman, Richard Emsley, Rowan Diamond, et al.
Schizophrenia Bulletin|April 29, 2024
Measurement of Adverse Events in Studies of Digital Health Interventions for Psychosis: Guidance and Recommendations Based on a Literature Search and Framework Analysis of Standard Operating ProceduresEmily Eisner, Cara Richardson, Neil Thomas, et al.
Behavioural and Cognitive Psychotherapy|November 9, 2023
Automated VR therapy for improving positive self-beliefs and psychological well-being in young patients with psychosis: a proof of concept evaluation of Phoenix VR self-confidence therapyDaniel Freeman, Jason Freeman, Memoona Ahmed, et al.
Psychological Medicine|June 14, 2022
Cognitive bias modification for paranoia (CBM-pa): a randomised controlled feasibility study in patients with distressing paranoid beliefsJenny Yiend, Charlene L M Lam, Nora Schmidt, et al.
BMJ Open|December 27, 2023
Randomised controlled trial of automated VR therapy to improve positive self-beliefs and psychological well-being in young people diagnosed with psychosis: a study protocol for the Phoenix VR self-confidence therapy trialDaniel Freeman, Jason Freeman, Aitor Rovira, et al.
BMJ Mental Health|November 12, 2025
Computerised adaptive testing across the paranoia continuumDaniel Freeman, Sinéad Lambe, Felicity Waite, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|September 4, 2024
Aripiprazole/Sertraline Combination: Clinical and Cost-Effectiveness in Comparison With Quetiapine for the Treatment of Bipolar Depression (ASCEnD Trial)-Protocol for a Nested Qualitative StudyIsobel Hoppe, Stuart Watson, Caroline Kemp, et al.
The Lancet. Psychiatry|September 2, 2018
Identifying research priorities for digital technology in mental health care: results of the James Lind Alliance Priority Setting PartnershipChris Hollis, Stephanie Sampson, Lucy Simons, et al.
Journal of Medical Internet Research|November 18, 2022
Estimating the Economic Value of Automated Virtual Reality Cognitive Therapy for Treating Agoraphobic Avoidance in Patients With Psychosis: Findings From the gameChange Randomized Controlled Clinical TrialJames Altunkaya, Michael Craven, Sinéad Lambe, et al.
Trials|December 2, 2024
Assessing the efficacy and safety of STOP (successful treatment for paranoia)-an app-based cognitive bias modification therapy for paranoia: a randomised clinical trial protocolJenny Yiend, Rayan Taher, Carolina Fialho, et al.
Pageof 5